World's Best Scientists 2026 revealed!
Award Badge
Immunology
USA
2026

D-Index & Metrics

Immunology

D-Index
146
Citations
93433
World Ranking
133
National Ranking
89

Medicine

D-Index
146
Citations
93366
World Ranking
1323
National Ranking
764

Research.com Recognitions

  • 2026 - Research.com Immunology in United States Leader Award
  • 2025 - Research.com Immunology in United States Leader Award
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Richard A. Koup is affiliated with the National Institute of Allergy and Infectious Diseases in the United States. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with a focus on Infectious Diseases, Immunology, Virology, Epidemiology, and Radiology, Nuclear Medicine and Imaging.

Their work covers a range of main topics related to immunology and infectious disease control, including:

  • HIV Research and Treatment
  • SARS-CoV-2 and COVID-19 Research
  • Immune Cell Function and Interaction
  • Immunotherapy and Immune Responses
  • T-cell and B-cell Immunology
  • Monoclonal and Polyclonal Antibodies Research
  • COVID-19 Clinical Research Studies

The scientist has contributed to multiple publication venues, frequently publishing in:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature Communications
  • The Journal of Immunology
  • Nature Medicine
  • Science Translational Medicine

Notable recent papers authored or co-authored by Richard A. Koup include the following:

  • Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial (2022), Science
  • Vaccination induces HIV broadly neutralizing antibody precursors in humans (2022), Science
  • A Covid-19 Milestone Attained - A Correlate of Protection for Vaccines (2022), New England Journal of Medicine
  • Defining the risk of SARS-CoV-2 variants on immune protection (2022), Nature
  • Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant in mice (2022), Nature Medicine

Frequent collaborators in research include:

  • Adrian B. McDermott
  • John R. Mascola
  • Peter D. Kwong
  • Nicole A. Doria-Rose
  • Amarendra Pegu

Richard A. Koup has also been recognized as a Member of the Association of American Physicians.

Best Publications

  • HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5.

    Tatjana Dragic;Virginia Litwin;Graham P. Allaway;Scott R. Martin

  • Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.

    R. A. Koup;J. T. Safrit;Yunzhen Cao;C. A. Andrews

  • Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection

    Rong Liu;William A Paxton;Sunny Choe;Daniel Ceradini

  • Changes in thymic function with age and during the treatment of HIV infection

    Daniel C. Douek;Richard D. McFarland;Phillip H. Keiser;Earl A. Gage

  • HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T-cells

    Michael R. Betts;Martha C. Nason;Sadie M. West;Stephen C. De Rosa

  • Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial

    Barton F. Haynes;Peter B. Gilbert;M. Juliana McElrath;Susan Zolla-Pazner

  • Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation

    Michael R. Betts;Jason M. Brenchley;David A. Price;Stephen C. De Rosa

  • Genotypic and phenotypic characterization of HIV-1 patients with primary infection

    Tuofu Zhu;Hongmei Mo;Ning Wang;Daniel S. Nam

  • The role of a mutant CCR5 allele in HIV–1 transmission and disease progression

    Yaoxing Huang;William A. Paxton;Steven M. Wolinsky;Avidan U. Neumann

  • HIV preferentially infects HIV-specific CD4 + T cells

    Daniel C. Douek;Jason M. Brenchley;Michael R. Betts;David R. Ambrozak

  • Antiretroviral-Drug Resistance among Patients Recently Infected with HIV

    Susan J. Little;Sarah Holte;Jean Pierre Routy;Eric S. Daar

  • Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells

    Jason M. Brenchley;Nitin J. Karandikar;Michael R. Betts;David R. Ambrozak

  • PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection.

    Constantinos Petrovas;Joseph P. Casazza;Jason M. Brenchley;David A. Price

  • Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial.

    Peter B Gilbert;Peter B Gilbert;David C Montefiori;Adrian B McDermott;Youyi Fong

  • HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression.

    Christine J. Pitcher;Claudia Quittner;Dolores M. Peterson;Mark Connors

  • Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection

    Michael R. Betts;David R. Ambrozak;Daniel C. Douek;Sebastian Bonhoeffer

  • CCR5 Levels and Expression Pattern Correlate with Infectability by Macrophage-tropic HIV-1, In Vitro

    Lijun Wu;William A. Paxton;Nasim Kassam;Nancy Ruffing

  • Emerging Concepts in the Immunopathogenesis of AIDS

    Daniel C. Douek;Mario Roederer;Richard A. Koup

  • Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques.

    Alexander I. Spira;Preston A. Marx;Bruce K. Patterson;James Mahoney

  • Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure.

    William A. Paxton;Scott R. Martin;Doris Tse;Thomas R. O'Brien

  • T Cell Dynamics in HIV-1 Infection*

    Daniel C. Douek;Louis J. Picker;Richard A. Koup

Frequent Co-Authors

Mario Roederer
Mario Roederer National Institute of Allergy and Infectious Diseases
Robert T. Bailer
Robert T. Bailer National Institute of Allergy and Infectious Diseases
Barney S. Graham
Barney S. Graham Morehouse School of Medicine
John R. Mascola
John R. Mascola ModeX Therapeutics
Daniel C. Douek
Daniel C. Douek National Institute of Allergy and Infectious Diseases
Gary J. Nabel
Gary J. Nabel ModeX Therapeutics
Julie E. Ledgerwood
Julie E. Ledgerwood National Institute of Allergy and Infectious Diseases
Adrian B. McDermott
Adrian B. McDermott National Institute of Allergy and Infectious Diseases
Michael R. Betts
Michael R. Betts University of Pennsylvania
Karin Loré
Karin Loré Karolinska Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open diverse career opportunities. Many aspiring healthcare professionals start with accessible programs, such as the easiest lpn programs to get into, which provide foundational nursing knowledge and patient care skills. These programs are often stepping stones to more advanced roles.

Nurse practitioners with a specialization in psychiatric and mental health play a vital role in immunology-related fields, especially in managing autoimmune and inflammatory conditions. To advance in this area, students might consider easiest nurse practitioner degree programs, allowing for efficient progression toward clinical practice.

Continuing education is essential, and the best programs offer strong clinical experience. The top pmhnp programs stand out for their high-quality clinical placements, ensuring students gain hands-on expertise necessary for patient care related to immunological health.

Cost is also a crucial factor. Aspiring professionals can find high-caliber education through cheapest pmhnp programs that balance affordability with comprehensive training, making advanced career pathways more accessible to a wider audience.

Best Scientists Citing Richard A. Koup

Trending Scientists